V158866
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for V158866, covering 2012-07-11 to 2017-04-11. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury [Phase 2]